Clinical efficacy and mechanistic evaluation of aflibercept for proliferative diabetic retinopathy (acronym CLARITY): a multicentre phase IIb randomised active-controlled clinical trial. (Q35775051)
Jump to navigation
Jump to search
scientific article published on 14 September 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | Clinical efficacy and mechanistic evaluation of aflibercept for proliferative diabetic retinopathy (acronym CLARITY): a multicentre phase IIb randomised active-controlled clinical trial. |
scientific article published on 14 September 2015 |
Statements
Clinical efficacy and mechanistic evaluation of aflibercept for proliferative diabetic retinopathy (acronym CLARITY): a multicentre phase IIb randomised active-controlled clinical trial (English)
Sobha Sivaprasad
David Hopkins
Joanna Kelly
Caroline Murphy
Jayashree Ramu
Negin Sarafraz-Shekary
Joana Vasconcelos
Beverley White-Alao
Philip Hykin
Rhiannon Tudor Edwards
14 September 2015
1 reference
1 reference
1 reference